When patient lives are at risk, every minute counts.
Drug diversion can happen in every stage of the medication-use process.
Uncovering these occurrences quickly can save lives.
Protect the facility from regulatory fines.
Prevent negative publicity.
Learn More: anigent.com
ANiGENT was established in 2019 to deliver a comprehensive, patent-pending drug diversion detection platform: Medication Administration & Analysis Program (MAAP Analytics®). Built by clinicians for clinicians and backed by over 10 years of refinements in a clinical setting, MAAP Analytics uses machine learning to track all users, all medications, in all locations and identify the root cause of discrepancies in minutes. Purpose-built and proven to produce actionable intelligence, MAAP Analytics is operationally efficient and configurable to any facility’s requirements. To learn more about ANiGENT and MAAP Analytics, visit ANiGENT.com.
This post is related to:
Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.
